The SCN2A Gene Convulsions Benign Familial Infantile 3 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the SCN2A gene, which are linked to Benign Familial Infantile Epilepsy (BFIE) type 3. This condition is characterized by the onset of seizures or convulsions in infants, typically between the ages of 3 months and 12 months. These seizures are generally not associated with long-term neurological deficits, making the condition "benign" in nature. However, early and accurate diagnosis is crucial for the effective management and treatment of the seizures, which can significantly improve the quality of life for affected infants.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test offers a comprehensive analysis of the SCN2A gene to detect any mutations that could be responsible for the disorder. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing technologies.
The cost of the SCN2A Gene Convulsions Benign Familial Infantile 3 Genetic Test is 4400 AED. This price reflects the intricate processes and sophisticated technology involved in accurately identifying the genetic variations linked to this specific form of epilepsy. By opting for this test, parents and healthcare providers can gain valuable insights into the genetic underpinnings of the infant's condition, enabling tailored treatment plans and informed decisions about care and management.
The PRRT2 gene convulsions familial infantile with paroxysmal choreoathetosis genetic test is a specialized diagnostic tool used to identify mutations in the PRRT2 gene, which are linked to a rare neurological disorder. This condition is characterized by early-onset convulsions, typically seen in infants, and can evolve into paroxysmal choreoathetosis in later life, manifesting as sudden, involuntary movements. The test plays a crucial role in confirming the diagnosis, enabling early intervention and tailored management strategies for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect abnormalities in the PRRT2 gene that are indicative of the disorder. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations associated with this condition. By opting for this test, families can gain valuable insights into the genetic underpinnings of the disorder, facilitating informed decisions about care and treatment options.
The "IGBP1 Gene Corpus Callosum Agenesis with Mental Retardation, Ocular Coloboma, and Micrognathia Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to detect mutations in the IGBP1 gene, which have been associated with a rare congenital condition characterized by the absence or underdevelopment of the corpus callosum (the part of the brain that connects the two hemispheres), intellectual disabilities, ocular coloboma (a defect in the eye's iris or retina), and micrognathia (a condition where the jaw is significantly smaller than normal).
The test plays a crucial role in the early diagnosis and management of the condition, providing essential information for healthcare providers and families. By understanding the genetic underpinnings of these symptoms, medical professionals can offer more personalized care plans, anticipate potential complications, and provide genetic counseling to affected families.
The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify mutations in the IGBP1 gene. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, patients and healthcare providers can expect reliable and comprehensive results that can significantly impact the management of this rare condition.
The "TUBB3 Gene Cortical Dysplasia Complex with Other Brain Malformations Type 1 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the TUBB3 gene, which are associated with a range of developmental brain abnormalities. This condition, known as Tubulinopathy, encompasses a spectrum of disorders that can lead to cortical dysplasia, a malformation of the brain cortex, among other neurological manifestations. These malformations can significantly impact brain function, leading to developmental delays, movement disorders, and epilepsy.
The test involves analyzing the patient's DNA to look for specific genetic alterations in the TUBB3 gene that are known to cause these complex brain malformations. Early diagnosis through genetic testing can be crucial for the management of the condition, allowing for tailored treatment plans and interventions that can improve the quality of life for affected individuals.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test cost is set at 4400 AED. This investment covers the detailed analysis required to detect the presence of mutations in the TUBB3 gene, providing essential information for patients and their families. Through this test, DNA Labs UAE aims to offer hope and support to those facing the challenges associated with cortical dysplasia complex and other related brain malformations.
The TUBB2A Gene Cortical Dysplasia Complex with Other Brain Malformations Type 5 Genetic Test is a specialized diagnostic examination offered at DNA Labs UAE. This test specifically targets the TUBB2A gene, mutations of which are associated with cortical dysplasia complex type 5, a rare genetic disorder that affects brain development. This condition can lead to a range of neurological problems, including developmental delays, seizures, and abnormalities in brain structure.
The test is designed to identify mutations in the TUBB2A gene, providing crucial information that can assist in the diagnosis, management, and treatment planning for affected individuals. By employing advanced genetic sequencing technologies, DNA Labs UAE ensures a high level of accuracy and reliability in the test results.
The cost of the TUBB2A Gene Cortical Dysplasia Complex with Other Brain Malformations Type 5 Genetic Test is 4400 AED. This price reflects the sophisticated nature of the genetic analysis and the specialized expertise required to interpret the results. For families facing the challenges of cortical dysplasia and related brain malformations, this test represents a valuable tool in understanding the genetic underpinnings of the condition and navigating the path forward in terms of medical care and support.
The "CNTNAP2 Gene Cortical Dysplasia-Focal Epilepsy Syndrome Genetic Test" is a specialized diagnostic examination conducted to detect mutations in the CNTNAP2 gene, which are linked to the development of Cortical Dysplasia-Focal Epilepsy (CDFE) syndrome. This condition is characterized by abnormalities in the brain's cortex that lead to epilepsy and other neurological issues. The test is a crucial tool for clinicians in diagnosing CDFE syndrome, enabling them to provide targeted treatments and management plans for affected individuals.
This genetic test is available at DNA Labs UAE, a leading facility known for its advanced diagnostic services and state-of-the-art technology. The cost of the test is 4400 AED, reflecting the sophisticated nature of the genetic analysis and the detailed insights it provides into the patient's condition. By identifying specific mutations in the CNTNAP2 gene, this test plays a vital role in the early detection and intervention of Cortical Dysplasia-Focal Epilepsy Syndrome, offering hope and improved outcomes for patients and their families.
The CFL1 gene plays a crucial role in various cellular processes, including cell division and movement. Mutations in this gene have been linked to corticobasal degeneration (CBD), a rare, progressive neurodegenerative disorder that affects the brain's cortex and basal ganglia, leading to a range of symptoms such as difficulty in movement, cognitive impairments, and behavioral changes. To aid in the diagnosis and understanding of the genetic basis of CBD associated with the CFL1 gene, DNA Labs UAE offers a specialized genetic test. Priced at 4400 AED, this test analyzes the CFL1 gene for specific mutations that may contribute to the development of corticobasal degeneration. By identifying these mutations, healthcare providers can gain valuable insights into the condition, enabling them to make more informed decisions regarding the patient's care and management.
The CR1 gene, also known as Complement Receptor 1, plays a critical role in the immune system by helping to regulate the complement system, which is part of the body's innate immune response. Mutations or deficiencies in the CR1 gene can lead to a range of immune system problems, including increased susceptibility to infections and autoimmune diseases.
A CR1 Deficiency Genetic Test is a specialized diagnostic tool used to detect mutations in the CR1 gene. This test is essential for individuals who may be experiencing symptoms related to immune system disorders or for those who have a family history of such conditions. Early detection through this genetic test can aid in the proper management and treatment of conditions associated with CR1 deficiency.
In the UAE, DNA Labs offers the CR1 Deficiency Genetic Test. The cost of the test is 4400 AED. DNA Labs UAE is known for its state-of-the-art facilities and advanced genetic testing services, providing accurate and reliable results. By opting for this test at DNA Labs UAE, individuals can gain valuable insights into their genetic makeup, particularly concerning the CR1 gene, enabling them and their healthcare providers to make informed decisions about their health management and treatment options.
The TMCO1 Gene Craniofacial Dysmorphism, Skeletal Anomalies, and Mental Retardation Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TMCO1 gene. These mutations are associated with a rare genetic disorder characterized by distinct facial features, abnormalities in skeletal development, and intellectual disability. The syndrome represents a complex condition that requires precise genetic analysis for accurate diagnosis and management.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the TMCO1 gene. This gene plays a crucial role in various developmental processes, and its mutation can lead to the syndrome's characteristic symptoms.
DNA Labs UAE offers this comprehensive genetic test for individuals showing symptoms of the syndrome or for those with a family history of genetic disorders. The cost of the test is set at 4400 AED, reflecting the intricate processes and sophisticated technology employed in identifying the genetic mutations associated with this condition. The results from this test can provide essential information for families and healthcare providers, guiding potential treatment options and management strategies for affected individuals.
The SLC6A8 gene creatine deficiency syndrome, also known as X-linked creatine transporter defect, is a genetic disorder that affects creatine transport into cells. This condition is significant because creatine plays a crucial role in energy storage and supply within cells, especially in the brain and muscles. Individuals with this syndrome may experience developmental delay, intellectual disabilities, speech and language impairments, and behavioral problems due to the lack of adequate creatine in certain cells.
To diagnose this condition, a specific genetic test is available that targets the SLC6A8 gene. This test can confirm the presence of mutations in the SLC6A8 gene that are responsible for the disorder. It is particularly useful for individuals showing symptoms of the disorder or for families with a history of the condition who are considering having children.
In the UAE, this genetic test is offered by DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. The cost of the SLC6A8 Gene Creatine Deficiency Syndrome X-Linked Genetic Test at DNA Labs UAE is 4400 AED. The test provides a crucial diagnostic tool for affected individuals and their families, enabling them to understand their condition better and to seek appropriate treatment and management strategies.
